AXA Framlington Health R Acc

Category Sector Equity Healthcare


star-filledstar-filledstar-filledstar-filled
Last buy/sell price

3,196.00p

arrow-up11.00p (+0.35%)

Fund Code

0350642

GB0003506424

Prices updated as at 04 Nov 2024
|
Prices in GBX

Investment objective
The aim of this Fund is to provide long-term capital growth over a period of 5 years or more. The Fund invests in shares of listed healthcare companies including producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world albeit the Fund tends to be biased towards the US, as this is where the majority of healthcare related companies are based. The Manager selects shares based upon analysis of a company’s financial status, quality of its management, expected profitability and prospects for growth.

Growth of 1,000 as of 05 Nov 2024, 06:11

Trailing returns (%) as of 05 Nov 2024, 06:11

Annual performance (%)

YearThis fundSector Equity Healthcare
30 Sep 13 - 30 Sep 1424.4122.59
30 Sep 14 - 30 Sep 1511.889.45
30 Sep 15 - 30 Sep 1620.3520.73
30 Sep 16 - 30 Sep 172.137.64
30 Sep 17 - 30 Sep 1818.0415.16
30 Sep 18 - 30 Sep 19-2.80-0.59
30 Sep 19 - 30 Sep 2017.6918.94
30 Sep 20 - 30 Sep 2112.8711.21
30 Sep 21 - 30 Sep 226.13-6.01
30 Sep 22 - 30 Sep 231.67-2.26
30 Sep 23 - 30 Sep 247.797.32

Trailing returns (%)

YearThis fundSector Equity Healthcare
1 Day-0.44-0.11
1 Month-2.12-1.55
3 Months-4.61-2.07
6 Months-1.210.95
1 Year11.2111.32
3 Years annualised3.41-3.49
5 Years annualised9.126.57
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2024 Morningstar. All rights reserved.